Tango Therapeutics, Inc. - Common Stock (NQ:TNGX)

20.11 -0.13 (-0.67%)

Streaming Delayed Price Updated: 2:30 PM EDT, May 26, 2026 Add to My Watchlist

Price and Volume

Volume	1,264,509
Open	20.61
Bid (Size)	20.12 (400)
Ask (Size)	20.17 (400)
Prev. Close	20.24
Today's Range	19.79 - 20.61
52wk Range	1.905 - 28.41
Shares Outstanding	88,406,523
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Boxer Capital’s $18 Million Corvus Pharma Bet Signals Confidence in This Biotech’s Next Phase ↗

May 17, 2026

Corvus Pharmaceuticals develops immuno-oncology therapies, advancing clinical candidates for cancer and immune-related conditions.

Via The Motley Fool

Why One Healthcare Fund Increased Its Kodiak Sciences Stake Amid an Eye-Popping Rally ↗

May 17, 2026

This clinical-stage biotech develops innovative retinal disease therapies, with its lead candidate advancing through late-stage trials.

Via The Motley Fool

Performance

YTD	+125.1%	+125.1%
1 Month	-23.6%	-23.6%
3 Month	+57.9%	+57.9%
6 Month	+94.6%	+94.6%
1 Year	+880.7%	+880.7%

More News

Vir Biotechnology Stock Has Doubled This Past Year. One Fund Just Bought 1.2 Million Shares ↗

May 17, 2026

Via The Motley Fool

Earnings Scheduled For November 4, 2025 ↗

November 04, 2025

Via Benzinga

A Peek at Tango Therapeutics's Future Earnings ↗

November 03, 2025

Via Benzinga

Acuta Capital Bet on Erasca (ERAS) and Targeted Cancer Treatments With a 354,575 Share Buy ↗

May 16, 2026

Via The Motley Fool

Tango Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Highlights

May 13, 2026

From Tango Therapeutics, Inc.

Via GlobeNewswire

Tango Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

May 04, 2026

From Tango Therapeutics Sub, Inc

Via GlobeNewswire

Tango Therapeutics Announces Leadership Appointments to Accelerate Late-Stage Development of Vopimetostat

April 15, 2026

From Tango Therapeutics Sub, Inc

Via GlobeNewswire

Tango Therapeutics President Sells 27,000 Shares for $572,000 as Share Price Skyrockets ↗

April 08, 2026

Via The Motley Fool

Tango Therapeutics Insider Sells $304,000 in Stock Amid a 36% Single-Day Surge ↗

March 30, 2026

Via The Motley Fool

Is Relay Therapeutics a Buy in 2026? One Institutional Investor Just Made a $6 Million Bet. ↗

March 19, 2026

Via The Motley Fool

Nextech Trims Kymera at a Recent High — think Foolishly before acting. ↗

March 19, 2026

Via The Motley Fool

The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology

March 19, 2026

From Equity Insider

Via GlobeNewswire

Investment Firm Doubles Down on Biotech Stock, Adds 386,000 Shares, According to Recent SEC Filing ↗

March 09, 2026

Via The Motley Fool

Investment Manager Loads Up on CELC Stock, Adds 135,000 Shares, According to Latest SEC Filing ↗

March 06, 2026

Via The Motley Fool

Investment Firm Builds Position in TERN Stock, According to Recent SEC Filing ↗

March 05, 2026

Via The Motley Fool

Investment Firm Bets Big on TNGX Stock With $9.5 Million Purchase, According to Recent SEC Filing ↗

March 04, 2026

Via The Motley Fool

The $20 Billion Question: Revolution Medicines Surges as Big Pharma Circles the Pan-RAS Leader

January 08, 2026

Via MarketMinute

TANGO THERAPEUTICS INC (NASDAQ:TNGX) Posts Strong Q3 Earnings Beat Amid Mixed Market Reaction ↗

November 04, 2025

Via Chartmill

Is Tango Therapeutics Stock a Buy, Sell, or Hold After Major Shareholder Third Rock Ventures Sold Nearly Half a Million Shares? ↗

October 31, 2025

Via The Motley Fool

Tango Therapeutics Touts Encouraging Data From Early-Stage Cancer Trial, Raises Capital To Fund Advancement ↗

October 23, 2025

Via Benzinga

Wondering what's happening in today's pre-market session? ↗

October 23, 2025

Via Chartmill

Tango Therapeutics Stock Soars Pre-Market On $225M Financing, Positive Study Data For Cancer Therapy ↗

October 23, 2025

Via Stocktwits

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 23, 2025

Via Benzinga

Frequently Asked Questions

Is Tango Therapeutics, Inc. - Common Stock publicly traded?

Yes, Tango Therapeutics, Inc. - Common Stock is publicly traded.

What exchange does Tango Therapeutics, Inc. - Common Stock trade on?

Tango Therapeutics, Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Tango Therapeutics, Inc. - Common Stock?

The ticker symbol for Tango Therapeutics, Inc. - Common Stock is TNGX on the Nasdaq Stock Market

What is the current price of Tango Therapeutics, Inc. - Common Stock?

The current price of Tango Therapeutics, Inc. - Common Stock is 20.11

When was Tango Therapeutics, Inc. - Common Stock last traded?

The last trade of Tango Therapeutics, Inc. - Common Stock was at 05/26/26 02:30 PM ET

What is the market capitalization of Tango Therapeutics, Inc. - Common Stock?

The market capitalization of Tango Therapeutics, Inc. - Common Stock is 1.78B

How many shares of Tango Therapeutics, Inc. - Common Stock are outstanding?

Tango Therapeutics, Inc. - Common Stock has 2B shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.